Quantum dot-based lab-on-a-bead system for multiplexed detection of free and total prostate-specific antigens in clinical human serum samples

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 11, Issue 5, 2015, Pages 1065-1075

  Brazhnik, Kristina ^a   Sokolova, Zinaida ^a,b   Baryshnikova, Maria ^a,b   Bilan, Regina ^a   Efimov, Anton ^c   Nabiev, Igor ^a,d   Sukhanova, Alyona ^a,d  

^a NATIONAL RESEARCH NUCLEAR UNIVERSITY MEPHI   (Russian Federation)

^b N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

^c SHUMAKOV NATIONAL MEDICAL RESEARCH CENTER OF TRANSPLANTOLOGY AND ARTIFICIAL ORGANS   (Russian Federation)

^d UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

Author keywords

Cancer markers; Flow cytometry; Fluorescent nanocrystals; Multiplexed analysis; Quantum dots; Suspension array

Indexed keywords

ANTIGENS; BIOMARKERS; DIAGNOSIS; DISEASES; FLOW CYTOMETRY; GRAPHENE QUANTUM DOTS; MICROBEADS; NANOCRYSTALS; SUSPENSIONS (FLUIDS); TUMORS; UROLOGY;

CANCER MARKERS; FLUORESCENT NANOCRYSTALS; MULTIPLEXED ANALYSIS; PROSTATE SPECIFIC ANTIGEN; QUANTITATIVE DETECTION; QUANTITATIVE DETERMINATIONS; SENSITIVITY AND SPECIFICITY; SUSPENSION ARRAY;

SEMICONDUCTOR QUANTUM DOTS;

CADMIUM SELENIDE; PROSTATE SPECIFIC ANTIGEN; QUANTUM DOT; ZINC SULFIDE; FLUORESCENT DYE; MICROSPHERE; TUMOR MARKER;

ANTIGEN DETECTION; ARTICLE; CANCER DIAGNOSIS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETER; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; MALE; PROSTATE CANCER; SCANNING PROBE MICROSCOPY; SENSITIVITY AND SPECIFICITY; SERUM; ULTRAMICROTOMY; BLOOD; CHEMISTRY; DEVICES; IMMUNOASSAY; PROSTATE TUMOR; PROTEIN MICROARRAY; VALIDATION STUDY;

BIOMARKERS, TUMOR; FLOW CYTOMETRY; FLUORESCENT DYES; HUMANS; IMMUNOASSAY; MALE; MICROSPHERES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PROTEIN ARRAY ANALYSIS; QUANTUM DOTS; SENSITIVITY AND SPECIFICITY;

EID: 84931044858     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2015.03.003     Document Type: Article

References (50)

1. Siegel R., Naishadham D., Jemal A. Cancer statistics. CA Cancer J Clin 2013, 63:11-30.
2. Sturgeon C. Practice guidelines for tumor marker use in the clinic. Clin Chem 2002, 48:1151-1159.
3. Bensalah K., Montorsi F., Shariat S.F. Challenges of cancer biomarker profiling. Eur Urol 2007, 52:1601-1609.
4. Maruvada P., Wang W., Wagner P.D., Srivastava S. Biomarkers in molecular medicine: cancer detection and diagnosis. Biotechniques 2005, 9-15. [Suppl].
5. Powers A.D., Palecek S.P. Protein analytical assays for diagnosing, monitoring, and choosing treatment for cancer patients. J Healthc Eng 2012, 3:503-534.
6. Cretich M., Damin F., Pirri G., Chiari M. Protein and peptide arrays: recent trends and new directions. Biomol Eng 2006, 23:77-88.
7. Witte K.L., Nock S. Recent applications of protein arrays in target identification and disease monitoring. Drug Discov Today Technol 2004, 1:35-40.
8. Petrik J. Diagnostic applications of microarrays. Transfus Med 2006, 16:233-247.
9. Gonzalez-Gonzalez M., Jara-Acevedo R., Matarraz S., Jara-Acevedo M., Paradinas S., Sayagues J.M., et al. Nanotechniques in proteomics: protein microarrays and novel detection platforms. Eur J Pharm Sci 2012, 45:499-506.
10. Sukhanova A., Nabiev I. Fluorescent nanocrystal-encoded microbeads for multiplexed cancer imaging and diagnosis. Crit Rev Oncol Hematol 2008, 68:39-59.
11. Sun K., Wang Q., Huang X.H., Zhen M.C., Li W., Zhang L.J. Establishment of multiplexed, microsphere-based flow cytometric assay for multiple human tumor markers. Acta Pharmacol Sin 2007, 28:2011-2018.
12. Kellar K.L., Iannone M.A. Multiplexed microsphere-based flow cytometric assays. Exp Hematol 2002, 30:1227-1237.
13. Fulton R.J., McDade R.L., Smith P.L., Kienker L.J., Kettman J.R. Advanced multiplexed analysis with the FlowMetrix system. Clin Chem 1997, 43:1749-1756.
14. duPont N.C., Wang K., Wadhwa P.D., Culhane J.F., Nelson E.L. Validation and comparison of luminex multiplex cytokine analysis kits with ELISA: determinations of a panel of nine cytokines in clinical sample culture supernatants. J Reprod Immunol 2005, 66:175-191.
15. Nolan J.P., Sklar L.A. Suspension array technology: evolution of the flat-array paradigm. Trends Biotechnol 2002, 20:9-12.
16. Kodadek T. Protein microarrays: prospects and problems. Chem Biol 2001, 8:105-115.
17. Elshal M.F., McCoy J.P. Multiplex bead array assays: performance evaluation and comparison of sensitivity to ELISA. Methods 2006, 38:317-323.
18. Sturgeon C.M., Viljoen A. Analytical error and interference in immunoassay: minimizing risk. Ann Clin Biochem 2011, 48:418-432.
19. Gershon D. Microarray technology: an array of opportunities. Nature 2002, 416:885-891.
20. Liotta L.A., Espina V., Mehta A.I., Calvert V., Rosenblatt K., Geho D., et al. Protein microarrays: meeting analytical challenges for clinical applications. Cancer Cell 2003, 3:317-325.
21. Ellington A.A., Kullo I.J., Bailey K.R., Klee G.G. Antibody-based protein multiplex platforms: technical and operational challenges. Clin Chem 2010, 56:186-193.
22. Geißler D., Stufler S., Löhmannsröben H.G., Hildebrandt N. Six-color time-resolved Förster resonance energy transfer for ultrasensitive multiplexed biosensing. J Am Chem Soc 2013, 135:1102-1109.
23. Khan S.S., Smith M.S., Reda D., Suffredini A.F., McCoy J.P. Multiplex bead array assays for detection of soluble cytokines: comparisons of sensitivity and quantitative values among kits from multiple manufacturers. Cytometry B Clin Cytom 2004, 61:35-39.
24. Wang Y., Fang F., Shi C., Zhang X., Liu L., Li J., et al. Evaluation of a method for the simultaneous detection of multiple tumor markers using a multiplex suspension bead array. Clin Biochem 2012, 45:1394-1398.
25. Braeckmans K., De Smedt S.C., Leblans M., Pauwels R., Demeester J. Encoding microcarriers: present and future technologies. Nat Rev Drug Discov 2002, 1:447-456.
26. Czarnik A.W. Encoding methods for combinatorial chemistry. Curr Opin Chem Biol 1997, 1:60-66.
27. Han M., Gao X., Su J.Z., Nie S. Quantum-dot-tagged microbeads for multiplexed optical coding of biomolecules. Nat Biotechnol 2001, 19:631-635.
28. Eastman P.S., Ruan W., Doctolero M., Nuttall R., de Feo G., Park J.S., et al. Qdot nanobarcodes for multiplexed gene expression analysis. Nano Lett 2006, 6:1059-1064.
29. Xie C., Wang G. Development of simultaneous detection of total prostate-specific antigen (tPSA) and free PSA with rapid bead-based immunoassay. J Clin Lab Anal 2011, 25:37-42.
30. Long Y., Zhang Z., Yan X., Xing J., Zhang K., Huang J., et al. Multiplex immunodetection of tumor markers with a suspension array built upon core-shell structured functional fluorescence-encoded microspheres. Anal Chim Acta 2010, 665:63-68.
31. Liu N., Liang W., Ma X., Li X., Ning B., Cheng C., et al. Simultaneous and combined detection of multiple tumor biomarkers for prostate cancer in human serum by suspension array technology. Biosens Bioelectron 2013, 47:92-98.
32. Resch-Genger U., Grabolle M., Cavaliere-Jaricot S., Nitschke R., Nann T. Quantum dots versus organic dyes as fluorescent labels. Nat Methods 2008, 5:763-775.
33. Medintz I.L., Uyeda H.T., Goldman E.R., Mattoussi H. Quantum dot bioconjugates for imaging, labelling and sensing. Nat Mater 2005, 4:435-446.
34. Nabiev I., Sukhanova A., Artemyev M., Oleinikov V. Fluorescent colloidal particles as detection tools in biotechnology systems. Colloidal Nanoparticles in Biotechnology 2008, 133-168. Wiley, London-Singapore-New York. A. Elissari (Ed.).
35. Sukhanova A., Venteo L., Devy J., Artemyev M., Oleinikov V., Pluot M., et al. Highly stable fluorescent nanocrystals as a novel class of labels for immunohistochemical analysis of paraffin-embedded tissue sections. Lab Invest 2002, 82:1259-1261.
36. Sukhanova A., Devy J., Venteo L., Kaplan H., Artemyev M., Oleinikov V., et al. Biocompatible fluorescent nanocrystals for immunolabeling of membrane proteins and cells. Anal Biochem 2004, 324:60-67.
37. Medintz I.L., Clapp A.R., Mattoussi H., Goldman E.R., Fisher B., Mauro J.M. Self-assembled nanoscale biosensors based on quantum dot FRET donors. Nat Mater 2003, 2:630-638.
38. Sukhanova A., Susha A.S., Bek A., Mayilo S., Rogach A.L., Feldmann J., et al. Nanocrystal-encoded fluorescent microbeads for proteomics: antibody profiling and diagnostics of autoimmune diseases. Nano Lett 2007, 7:2322-2327.
39. Gao Y., Stanford W.L., Chan W.C. Quantum-dot-encoded microbeads for multiplexed genetic detection of non-amplified DNA samples. Small 2011, 7:137-146.
40. Wang X., Wang G., Li W., Zhao B., Xing B., Leng Y., et al. NIR-emitting quantum dot-encoded microbeads through membrane emulsification for multiplexed immunoassays. Small 2013, 9:3327-3335.
41. Yu H.W., Kim I.S., Niessner R., Knopp D. Multiplex competitive microbead-based flow cytometric immunoassay using quantum dot fluorescent labels. Anal Chim Acta 2012, 750:191-198.
42. Caruso F. Nanoengineering of particle surfaces. Adv Mater 2001, 13:11-22.
43. Susha A.S., Caruso F., Rogach A.L., Sukhorukov G.B., Kornowski A., Mohwald H., et al. Formation of luminescent spherical core-shell particles by the consecutive adsorption of polyelectrolyte and CdTe (S) nanocrystals on latex colloids. Colloids Surf A Physicochem Eng Asp 2000, 163:39-44.
44. Sukhanova A., Even-Desrumeaux K., Chames P., Baty D., Artemyev M., Oleinikov V., et al. Engineering of ultra-small diagnostic nanoprobes through oriented conjugation of single-domain antibodies and quantum dots. Nat Protoc 2012, [http://www.nature.com/protocolexchange/protocols/2463]. 10.1038/protex.2012.042.
45. Sukhanova A., Even-Desrumeaux K., Kisserli A., Tabary T., Reveil B., Millot J.M., et al. Oriented conjugates of single-domain antibodies and quantum dots: toward a new generation of ultrasmall diagnostic nanoprobes. Nanomedicine: NBM 2012, 8:516-525.
46. Mochalov K.E., Efimov A.E., Bobrovsky A., Agapov I.I., Chistyakov A.A., Oleinikov V., et al. Combined scanning probe nanotomography and optical microspectroscopy: a correlative technique for 3D characterization of nanomaterials. ACS Nano 2013, 7:8953-8962.
47. Fuzery A.K., Levin J., Chan M.M., Chan D.W. Translation of proteomic biomarkers into FDA approved cancer diagnostics: issues and challenges. Clin Proteomics 2013, 10:13-27.
48. Lilja H., Ulmert D., Vickers A.J. Prostate-specific antigen and prostate cancer: prediction, detection and monitoring. Nat Rev Cancer 2008, 8:268-278.
49. Catalona W.J., Partin A.W., Slawin K.M., Brawer M.K., Flanigan R.C., Patel A., et al. Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial. JAMA 1998, 279:1542-1547.
50. Slev P.R., La'ulu S.L., Roberts W.L. Intermethod differences in results for total PSA, free PSA, and percentage of free PSA. Am J Clin Pathol 2008, 129:952-958.